Search

everythinglearnresearchcommunity

for

Search:↓

A woman with type 2 diabetes developed alopecia areata, suggesting a link between the two autoimmune conditions.

Lichen planus is not linked to metabolic syndrome, but it is associated with higher rates of high blood pressure, high triglycerides, and low HDL cholesterol.

Skin symptoms can indicate endocrine disorders and have various treatments.

Eating less calories, focusing on complex carbs, and reducing fats can help manage type II diabetes.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Men with certain patterns of hair loss, especially the U pattern, are more likely to develop insulin resistance.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

The method can help diagnose and monitor diabetes by analyzing hair.

Aging changes skin cells, leading to different DNA methylation and gene activity, affecting cell metabolism and aging signs.

Testosterone raises blood pressure by affecting kidney function and brain gene regulation over time.

High insulin levels are more common and a better predictor of carbohydrate issues in women with PCOS than glucose tolerance tests.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Improving dermal papilla cells can help regenerate hair follicles.

Ethosomal carriers improve drug delivery through the skin better than traditional methods.

There is no significant link between male pattern baldness and insulin resistance.

The document concludes that understanding hair follicles requires more research using computational methods and an integrative approach, considering the current limitations in hair treatment products.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Certain hormone medications can treat symptoms like acne and unwanted hair, regulate periods, and prevent pregnancy in women and teenage girls.

Excess male hormones in postmenopausal women can cause health issues and increase the risk of heart disease and diabetes; treatment depends on the cause.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Postmenopausal women with hyperandrogenism didn't have better metabolic health even after their testosterone levels became normal.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Metformin is less effective in men with early-onset hair loss.

Skin tags in obese individuals may indicate higher cardiovascular risk.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.